4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aldeyra Therapeutics, Inc. (ALDX) operates in the Biotechnology industry and is headquartered in Lexington, United States with about 7 employees. Its market capitalization is roughly $92 million. In the fiscal year ended 2025-12-31, ALDX reported $0M in revenue and ($34M) in net income.
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($35M) | ($60M) | ($43M) | ($63M) | — |
| Net Income | ($34M) | ($56M) | ($38M) | ($62M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($7M) | ($8M) | ($10M) | ($10M) |
| Net Income | ($4M) | ($6M) | ($8M) | ($10M) | ($10M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $72M | $105M | $148M | $181M | — |
| Total Liabilities | $28M | $34M | $28M | $30M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALDX viewer.
About TickerBase · Data methodology & sources